ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Hormonal therapy-based treatments
Sponsor: National Taiwan University Hospital
Collaborators: Novartis